Huafeng Kang
- Molecular Biology top 5%
- Oncology top 5%
- Cancer Research top 2%
- Pulmonary and Respiratory Medicine top 5%
- Pharmacology top 5%
- Topics
- Breast Cancer Treatment Studies (14 papers)Cancer-related molecular mechanisms research (12 papers)Flavonoids in Medical Research (11 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Huafeng Kang
121 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Molecular Biology 1.3k
- Oncology 836
- Cancer Research 728
- Pulmonary and Respiratory Medicine 426
- Pharmacology 310
Countries citing papers authored by Huafeng Kang
This map shows the geographic impact of Huafeng Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huafeng Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huafeng Kang more than expected).
Fields of papers citing papers by Huafeng Kang
This network shows the impact of papers produced by Huafeng Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huafeng Kang. The network helps show where Huafeng Kang may publish in the future.
Co-authorship network of co-authors of Huafeng Kang
This figure shows the co-authorship network connecting the top 25 collaborators of Huafeng Kang. A scholar is included among the top collaborators of Huafeng Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huafeng Kang. Huafeng Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 0 | |
| 8 | 13 | |
| 9 | 8 | |
| 10 | 4 | |
| 11 | 16 | |
| 12 | 4 | |
| 13 | 16 | |
| 14 | 15 | |
| 15 | 13 | |
| 16 | 26 | |
| 17 | 32 | |
| 18 | 1 | |
| 19 | 17 | |
| 20 | [HER-2 expression in local advanced breast cancer and the efficacy of neoadjuvant chemotherapy regimens]. | 4 |
About Huafeng Kang
Huafeng Kang is a scholar working on Cancer Research, Oncology and Pharmacology, having authored 132 papers that have together received 2.9k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (14 papers), Cancer-related molecular mechanisms research (12 papers) and Flavonoids in Medical Research (11 papers). The work is most often cited by research in Cancer Research (728 citations), Oncology (836 citations) and Molecular Biology (1.3k citations). Huafeng Kang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Zhijun Dai, Xi-Jing Wang, Shuai Lin, Xiaobin Ma, Yi Zheng, Yujiao Deng, Haitao Guan, Linghui Zhou, Zhen Zhai and Na Li. Their work appears in journals such as Advanced Functional Materials, Journal of Agricultural and Food Chemistry and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.